Alterra Stock To Go Ex-dividend Tomorrow (ALTE)

NEW YORK ( TheStreet) -- The ex-dividend date for Alterra Capital Holdings (Nasdaq: ALTE) is tomorrow, February 17, 2012. Owners of shares as of market close today will be eligible for a dividend of 14 cents per share. At a price of $23.18 as of 9:30 a.m. ET, the dividend yield is 2.4%.

The average volume for Alterra has been 455,200 shares per day over the past 30 days. Alterra has a market cap of $2.53 billion and is part of the financial sector and insurance industry. Shares are down 0.9% year to date as of the close of trading on Wednesday.

Alterra Capital Holdings Limited, through its subsidiaries, provides specialty insurance and reinsurance products to corporations, public entities, and property and casualty insurers principally in Bermuda, Ireland, the United States, and the United Kingdom. The company has a P/E ratio of 38.4, above the average insurance industry P/E ratio of 24.5 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Alterra as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Alterra Ratings Report.

See our dividend calendar or top-yielding stocks list.

null

More from Markets

FCC Rocks Sinclair-Tribune Merger; Arconic Makes Perfect PE Sense -- ICYMI

FCC Rocks Sinclair-Tribune Merger; Arconic Makes Perfect PE Sense -- ICYMI

Bank of America Rips on Earnings Beat, But Analysts See Even More Gains Ahead

Bank of America Rips on Earnings Beat, But Analysts See Even More Gains Ahead

Will Micron Buy Back $10 Billion in Stock? Analyst Says Yes

Will Micron Buy Back $10 Billion in Stock? Analyst Says Yes

Stocks End Mixed as Dow Rises, S&P 500 and Nasdaq Slip

Stocks End Mixed as Dow Rises, S&P 500 and Nasdaq Slip

What to Watch When UnitedHealth Reports Results

What to Watch When UnitedHealth Reports Results